# FDA Inspection 1216201 - Erregierre S.p.A. - September 23, 2022

Source: https://www.keypedia.com/records/fda_inspections/erregierre-spa/5dde0449-f4d2-421a-b4c7-ac2a2016ac45
Source feed: FDA_Inspections

> FDA Inspection 1216201 for Erregierre S.p.A. on September 23, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1216201
- Company Name: Erregierre S.p.A.
- Inspection Date: 2022-09-23
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1079021 - 2018-06-14](https://www.keypedia.com/records/fda_inspections/erregierre-spa/b564452f-9d92-468f-9827-7cfd0c1b817d)
- [FDA Inspection 810976 - 2012-11-16](https://www.keypedia.com/records/fda_inspections/erregierre-spa/10af9a10-f51c-4a4f-abe5-2a454d9167f3)
- [FDA Inspection 666143 - 2010-05-20](https://www.keypedia.com/records/fda_inspections/erregierre-spa/de614264-4bfe-4479-8a29-0f20ff1aa47b)

Company: https://www.keypedia.com/companies/erregierre-spa/5563956d-2c26-41b9-9884-19808b0084b7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c